Tensiomin (captopril) was tested in 23 patients with chronic heart failure for 7.5 months on the average. In 9 outpatients suffering from congestive cardiomyopathy the effect of Tensiomin as an adjuvant to digitalis, diuretic, vasodilator etc. was evaluated by non-invasive methods. During the 3-month follow-up period the heart rate was decreased and the PEP/LVET ratio was improved. The parameters calculated from the X-ray examination (cardiothoracic index, cardiac volume index) indicated the regression of cardiomegaly. Radioisotopic circulatory examinations (systolic volume index, cardiac output index) indicated an increase in cardiac performance. In addition to the significant changes of these parameters the patients' clinical state was also improved in all cases as assessed according to the NYHA classification. Significant side effects were not observed during the treatment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

tensiomin captopril
8
chronic heart
8
heart failure
8
study tensiomin
4
captopril chronic
4
failure tensiomin
4
captopril tested
4
tested patients
4
patients chronic
4
failure months
4

Similar Publications

The aim of this study was to explore and compare initial treatment effects of captopril (Tensiomin) and sodium dimercaptosulphonate (DMPS) on a relatively large series of Wilson's disease inpatients. Two important markers of anticopper efficacy: serum sulphydryl and 24 h urinary copper levels in the patients were evaluated before and after treatment. The patients were randomly subdivided into 4 groups to allow statistical analysis (ANOVA) of the values recorded.

View Article and Find Full Text PDF

The authors of the present report reviewed the literature of various bioanalytical methods for the pharmacokinetics and metabolism of captopril and present their own results obtained in bioanalytical and pharmacokinetic studies. The authors performed a detailed comparative clinical, pharmacokinetic and bioequivalence study, in Hungary, with 3 different captopril tablets, 50 mg each, namely with Tensiomin (EGIS Pharmaceuticals Ltd.), as test preparation and Capoten (E.

View Article and Find Full Text PDF

[Pharmaceutical technology of Tensiomin].

Acta Pharm Hung

July 1997

EGIS Gyógyszergyár Rt, Budapest.

The physical chemical properties, stability and incompatibility of captopril (the active ingredient of Tensiomin tablets) have been discussed. Captopril has two polimorphic crystal modifications, the form I. of higher melting point is applied in the therapy.

View Article and Find Full Text PDF

The effect of the angiotensin-converting enzyme inhibitor, Tensiomin, has been examined in patients suffering from ischaemic dilatative cardiomyopathy who had become unresponsive to combined vasodilatator--diuretic--digitalis therapy. The results were evaluated according to the changes in NYHA classes and echocardiographic parameters. Significant improvement was observed in response to Tensiomin in 38 of the 52 patients (73%).

View Article and Find Full Text PDF

The authors describe the case of a 70-year-old female patient with ischaemic heart disease with an implanted pacemaker on account of sick-sinus syndrome, who after classical treatment with diuretics and cardiotonics suffered from frequent relapses of global decompensation of the circulation. After administration of the ACE inhibitor--Tensiomin--within a very short time (days) normalization of all indicators of previously severe congestion was found. During the subsequent follow up no relapse of decompensation occurred.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!